
March 29, 2026 12:12 AM

First Oral Alzheimer’s Pill Shows Promise for High-Risk Patients

BridgeBio’s Experimental Drug Hits Key Goals in Major Muscle-Disorder Trial

Revvity Raises Full-Year Profit Forecast on Strong Diagnostics Demand


UnitedHealth Investors Rally Behind New CEO as Turnaround Hope Grows

Study Links Artificial Sweeteners to Cognitive Decline and Accelerated Brain Aging

China’s Innovent Claims Its GLP-1 Is Superior to Novo Nordisk’s Blockbuster Semaglutide

Novartis to Acquire Avidity Biosciences in $1.2 Billion Biotech Takeover


More From Next Click News
Explore Next Click News Categories